期刊文献+

发酵方式对放线菌WS-22011次生代谢产物的影响 被引量:2

Effect of Fermentation Methods on Secondary Metabolites of Actinomycete WS-22011
下载PDF
导出
摘要 以放线菌WS-22011为研究对象,通过研究摇瓶发酵和发酵罐发酵两种不同发酵方式下WS-22011产生的次生代谢产物多样性及产量随时间变化的动态趋势,确定WS-22011最佳发酵方式及兼顾代谢产物多样性、产量的最佳发酵时间。结果表明,对于WS-22011菌株来说,在发酵罐发酵和摇瓶发酵两种发酵方式下产生的次生代谢产物及多样性基本一致,两种发酵方式均可以保证次生代谢产物的多样性和产量,但次生代谢产物最大总产量出现的时间有所差异,从节约时间及成本考虑,可首选发酵罐发酵;而如果需得到所有的次生代谢产物,则首选摇瓶发酵,且发酵时间需适当延长。通过制备分离得到了4个具有较高活性的化合物,LC-MS分析结果表明为碰撞霉素。 The dynamics of diversity and yield of secondary metabolites according to fermentation time of Actinomycete WS-22011 under shake-flask fermentation and tank fermentation was studied to optimize the fermentation method and time in consideration of both diversity and yield of secondary metabolites.The results showed that the diversity of WS-22011's secondary metabolites were basically similar under both fermentation methods,but the time for maximum metabolic production differed.Therefore,tank fermentation would be a better choice for saving time and cost;While shake-flask fermentation with long fermentation time should be used if the diversity of secondary metabolites was in first consideration.4 active compounds were isolated,purred and identified as collismycins by LC-MS.
出处 《湖北农业科学》 北大核心 2011年第24期5234-5238,共5页 Hubei Agricultural Sciences
基金 国家公益性行业(农业)科研专项资助(200903052) 湖北省农业科技创新中心资助项目(2007-620-001-03)
关键词 放线菌WS-22011 发酵 次生代谢产物 产量动态变化 Actinomycete WS-22011 fermentation secondary metabolites production dynamic
  • 相关文献

参考文献10

  • 1BERDY J. Bioactive microbial metabolites [J]. J Antibiot,2005, 58(1):1-26.
  • 2BARBEREL S,WALKER J. The effect of aeration upon the secondary metabolism of microorganisms [J]. Biotechnol Genet Eng Rev,2000,17:281-323.
  • 3任锡伦 张汉卿.茄子对褐纹病菌抗性鉴定研究[J].吉林农业大学学报,1993,15(3):34-38.
  • 4StinzianiJ.国外农学:向日葵[M].,1989,2..
  • 5OMURA S. Trends in the search for bioactive microbial metabolites [J]. Journal of Industrial Microbiology,1992,10(3-4) : 135-156.
  • 6王辂,褚以文.微生物来源先导化合物的研究策略[J].中国天然药物,2006,4(3):162-167. 被引量:9
  • 7王开梅 江爱兵 张亚妮 等.微生物源农药先导化合物的筛选策略与研究进展.湖北农业科学,2009,48(10):45-51.
  • 8张亚妮,王开梅,张志刚,江爱兵,万忠义,杨自文.放线菌菌株WS-13182产生的活性物质的分离纯化[J].湖南农业科学,2009(11):33-36. 被引量:2
  • 9SHIND0 K,YAMAGISHI Y,OKADA Y,et al. Collismyeins A and B,novel non-steroidal inhibitors of dcxamethasone-gjueo- cortieoid receptor binding [Jl. J Antibiot, 1994,47(9) : 1072.
  • 10STADLER M,BAUCH F,HENKEL T,et al. Antifungal acti- nomycete metabolites discovered in a differential cell-based screening using a recombinant TOPO1 deletion mutant strain[Jl. Arch Pharm (Weinheim) ,2001,334(5) : 143-147.

二级参考文献42

  • 1喻凌寒,杨运云,闫世平,陈江韩,李光宪,牟德海,蔡大川.LC—ESI/MS分析食品中微量苏丹红Ⅰ~Ⅳ[J].分析测试学报,2005,24(4):28-31. 被引量:46
  • 2高楠,张庆林.微生物代谢产物库研究进展[J].微生物学杂志,2005,25(5):104-106. 被引量:2
  • 3王辂,褚以文.微生物来源先导化合物的研究策略[J].中国天然药物,2006,4(3):162-167. 被引量:9
  • 4尚庆坤,玄玉实,朱东霞,崔秀君.高效制备液相色谱法分离制备菱角壳中的生物碱[J].东北师大学报(自然科学版),2007,39(2):82-86. 被引量:29
  • 5Lutz Weber. High diversity combinatorial libraries [J].Current Opinion in Chemical Biology. 2000, 4: 295-302.
  • 6[1]Shu YZ.Recent natural products based drug development:a pharmaceutical industry perspective[J].J Nat Prod,1998,61:1053-1071.
  • 7[2]Knight V,Sanglier JJ,DiTullio D,et al.Diversifying microbial natural products for drug discovery[J].Appl Microbiol Biotechnol,2003,62:446-458.
  • 8[3]Brian C,Jane CD,Alastair B,et al.Application of high-throughput screening techniques to drug discovery[J].Prog Med Chem,2000,37:83-133.
  • 9[4]Giuliano KA,Debiasio RL,Dunlay RT,et al.High-content screening:a new approach to easing key bottlenecks in the drug discovery process[J].J Biomol Screen,1997,2:249-259.
  • 10[5]Burbaum JJ,Ohlmeyer MH,Reader JC,et al.A paradigm for drug discovery employing encoded combinatorial libraries[J].Proc Natl Acad Sci USA,1995,92:6027-6031.

共引文献10

同被引文献26

  • 1聂存喜,张文举,闫理东,蒋粒薪,马贵军.热带假丝酵母固体发酵代谢物提取方法的比较分析[J].动物营养学报,2012,24(8):1610-1614. 被引量:1
  • 2李寿臣,唐洪光.紫花苜蓿食用营养与人体健康[J].中国食物与营养,2004,10(12):45-46. 被引量:25
  • 3卢成,曾昭海,张涛,戚志强,胡跃高.紫花苜蓿生物活性成分研究进展[J].草业科学,2005,22(9):28-32. 被引量:87
  • 4张勇,汪儆,林东康.苜蓿总甙对肉仔鸡生长性能、血脂及胴体品质的影响[J].动物营养学报,2005,17(4):46-50. 被引量:26
  • 5丛学滋 秦孟根 李子行 等.苜蓿皂甙的降血胆固醇及减轻实验性动脉粥样硬化形成的作用.中国药理学通报,1988,4(5):293-297.
  • 6STORY J A,LEPAGE S L,PETRO M S,et al.Interactions of alfalfa plant and sprout saponins with cholesterol in vitro and in cholestrerol-fed rats [J]. Am J Clin Nutr, 1984,39 (6) :917- 929.
  • 7KHALEEL A E,GAD M Z, EL-MARAGHY S A,et al. Study of hypoeholesterolemic and antiatherosclerotic properties of Medicago sativa L cultivated in Egypt [J]. Journal of Food and Drug Analysis, 2005,13 (3) : 212-218.
  • 8PONTE P I P,MENDES I,QUARESMA M,et al. Cholesterol levels and sensory characteristics of meat from broilers con- suming moderate to high levels of alfalfa[J]. Poultry Science, 2004,83(5) :810-814.
  • 9苏云驰.徐建平,余从洪.苜蓿皂甙的提取和精制方法及苜蓿皂甙制剂[P].CN03139922,2004-02-11.
  • 10PAUFIQUE J.Activities of an active principle obtained from powdered alfalfa seeds(Medicago sativa),active principle used and process of obtaining the same [P]. US 2005208160A1,2005-08-05.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部